Aurélie Russo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aurélie Russo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
C. Dot
Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
1 shared publicationC. Lagenaite
Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
1 shared publication- Corinne Dot
Department of Ophthalmology, Hôpital Edouard Herriot, Centre Hospitalier Universitaire de Lyon Grange Blanche, 5, Place d’Arsonval, 69437 Lyon, France
1 shared publication E. Agard
Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
1 shared publication- Emilie Agard
Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France
1 shared publication G. Ract-Madoux
Service d'ophtalmologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
1 shared publication
Latest Publications
- 14 July 2016
- Published by S. Karger AG in Ophthalmologica
- Vol. 236 (1) , 43-47
Intraocular Pressure Spikes after Aflibercept Intravitreal Injections
The objective of this study was to assess the intraocular pressure (IOP) as well as the anatomical modifications of the anterior segment following an aflibercept injection. Patients underwent an aflibercept intravitreal injection (IVI) (0.05 ml) with a 30.5-gauge needle and an antireflux system. IOP was assessed before injection (T0), immediately after (T1), and 5 min (T5), 15 min (T15), and 45 min (T45) after the IVI. Before the IVI and immediately after the T1 measurement, a PENTACAM® acquisition was used to evaluate the anterior chamber parameters (anterior chamber volume, depth and measure of the iridocorneal angle). At T0, IOP was 12.9 ± 1.3 mm Hg. IOP significantly increased after IVI (42.7 ± 3 mm Hg, p < 0.001). IOP returned to baseline at T45 (13.0 ± 1.2 mm Hg, p = 0.877). Anterior chamber volume decreased after IVI (160.6 vs. 168.3 mm3, p = 0.002). No significant changes were found for iridocorneal angle and anterior chamber depth. Aflibercept IVI causes an acute increase in IOP over a short period without iridocorneal angle closure.
- 14 July 2016
- Published by S. Karger AG in Ophthalmologica
- Vol. 236 (1) , 43-47
Intraocular Pressure Spikes after Aflibercept Intravitreal Injections
The objective of this study was to assess the intraocular pressure (IOP) as well as the anatomical modifications of the anterior segment following an aflibercept injection. Patients underwent an aflibercept intravitreal injection (IVI) (0.05 ml) with a 30.5-gauge needle and an antireflux system. IOP was assessed before injection (T0), immediately after (T1), and 5 min (T5), 15 min (T15), and 45 min (T45) after the IVI. Before the IVI and immediately after the T1 measurement, a PENTACAM® acquisition was used to evaluate the anterior chamber parameters (anterior chamber volume, depth and measure of the iridocorneal angle). At T0, IOP was 12.9 ± 1.3 mm Hg. IOP significantly increased after IVI (42.7 ± 3 mm Hg, p < 0.001). IOP returned to baseline at T45 (13.0 ± 1.2 mm Hg, p = 0.877). Anterior chamber volume decreased after IVI (160.6 vs. 168.3 mm3, p = 0.002). No significant changes were found for iridocorneal angle and anterior chamber depth. Aflibercept IVI causes an acute increase in IOP over a short period without iridocorneal angle closure.
- 1 October 2014
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 37 (8) , 629-634
Rétinopathie de haute altitude : à propos de 3 cas
- 1 October 2014
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 37 (8) , 629-634
Rétinopathie de haute altitude : à propos de 3 cas